Literature DB >> 21369720

Atypical diaphyseal femoral fractures--new aspects.

Frieda Feldman1.   

Abstract

Post menopausal osteoporotic fractures are a major public health concern worldwide with oral bisphosphonates favored for their prevention and treatment. Recent interest has centered on clinically observed, unusually sited femoral diaphyseal fractures, particularly attributed to alendronate. Their imaging presentations on routine radiographs, alternate imaging modalities, and associated pitfalls in nine fractures in six patients are selectively illustrated by seven fractures in four patients that serve to emphasize the following: (1) Bisphosphonates other than alendronate have been used for treating various bone diseases in children and men as well as osteoporotic women. (2) Effects may differ with each bisphosphonate's route of administration and prolongation of activity, despite discontinuation. Prior investigations and theoretical mechanisms of bisphosphonates as a class rather than with a specific alendronate association are reviewed to provide a broader basis for evaluating their recently observed clinical and radiographic complications.

Entities:  

Mesh:

Year:  2011        PMID: 21369720     DOI: 10.1007/s00256-011-1130-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  26 in total

1.  Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.

Authors:  Sarah Shock Chan; Zehava Sadka Rosenberg; Keith Chan; Craig Capeci
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

2.  Long-term safety of bisphosphonates.

Authors:  Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2005-03       Impact factor: 5.958

3.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

4.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

Review 5.  Bone microdamage and skeletal fragility in osteoporotic and stress fractures.

Authors:  D B Burr; M R Forwood; D P Fyhrie; R B Martin; M B Schaffler; C H Turner
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

6.  Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Authors:  S-K Goh; K Y Yang; J S B Koh; M K Wong; S Y Chua; D T C Chua; T S Howe
Journal:  J Bone Joint Surg Br       Date:  2007-03

Review 7.  Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

Authors:  John P Bilezikian
Journal:  Am J Med       Date:  2009-02       Impact factor: 4.965

8.  Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate.

Authors:  Jörg Schilcher; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

9.  An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Authors:  Ernest Beng Kee Kwek; Seo Kiat Goh; Joyce Suang Bee Koh; Meng Ai Png; Tet Sen Howe
Journal:  Injury       Date:  2008-01-28       Impact factor: 2.586

10.  Giant osteoclast formation and long-term oral bisphosphonate therapy.

Authors:  Robert S Weinstein; Paula K Roberson; Stavros C Manolagas
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

View more
  4 in total

1.  VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT.

Authors:  Shirou Ishii; Ken Kikuchi; Masayuki Miyajima; Kotaro Sakuma; Fumio Shishido
Journal:  Fukushima J Med Sci       Date:  2015-05-03

Review 2.  Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.

Authors:  Ian R Reid
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

Review 3.  Current perspectives on bisphosphonate treatment in Paget's disease of bone.

Authors:  Winnie Zee Man Wat
Journal:  Ther Clin Risk Manag       Date:  2014-11-20       Impact factor: 2.423

Review 4.  Management of Subtrochanteric Proximal Femur Fractures: A Review of Recent Literature.

Authors:  Christopher Jackson; Mina Tanios; Nabil Ebraheim
Journal:  Adv Orthop       Date:  2018-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.